Patents by Inventor Anthonius Josef Swaak

Anthonius Josef Swaak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of erythropoietin in the treatment of chronic inflammation
    Patent number: 9155782
    Abstract: A novel use of the known protein erythropoietin (EPO), and/or a derivative, and/or a fragment thereof, is disclosed. EPO is used as a pharmaceutical for the treatment of chronic inflammations. A particularly beneficial result is seen in patients suffering from rheumatoid arthritis (RA). Significant effects are seen in clinical variables such as morning stiffness, swollen joints, and the like.
    Type: Grant
    Filed: June 11, 2007
    Date of Patent: October 13, 2015
    Assignee: Roche Diagnostics GMBH
    Inventor: Anthonius Josef Swaak
  • Use of erythropoietin in the treatment of rheumatoid arthritis
    Patent number: 7344717
    Abstract: A novel use of the known protein Erythropoietin (EPO) and/or a derivative and/or a fragment thereof is disclosed. EPO is used as a pharmaceutical for the treatment of chronic inflammations. A particularly beneficial result is seen in patients suffering from rheumatoid arthritis (RA). Significant effects are seen in clinical variables such as morning stiffness, swollen joints, and the like.
    Type: Grant
    Filed: October 26, 1995
    Date of Patent: March 18, 2008
    Assignee: Roche Diagnostics GmbH
    Inventor: Anthonius Josef Swaak